Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol
Status:
Unknown status
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study has been designed to test whether using Thymoglobulin with low dose Cyclosporine
and early steroid dosage reduction will minimize both kidney rejection and the development of
new onset diabetes mellitus after renal transplant.
Phase:
Phase 4
Details
Lead Sponsor:
University Health Network, Toronto
Collaborators:
Genzyme, a Sanofi Company St. Michael's Hospital, Toronto St. Paul's Hospital, Canada Unity Health Toronto